CTE Stock Overview
Cryosite Limited offers outsourced clinical trials logistic services in Australia.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
Cryosite Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.72 |
| 52 Week High | AU$0.87 |
| 52 Week Low | AU$0.40 |
| Beta | 0.57 |
| 1 Month Change | -0.68% |
| 3 Month Change | 9.02% |
| 1 Year Change | 61.11% |
| 3 Year Change | 1,267.92% |
| 5 Year Change | 559.09% |
| Change since IPO | 64.78% |
Recent News & Updates
Shareholder Returns
| CTE | AU Life Sciences | AU Market | |
|---|---|---|---|
| 7D | 0.7% | 0.2% | 0.6% |
| 1Y | 61.1% | -48.0% | 3.5% |
Return vs Industry: CTE exceeded the Australian Life Sciences industry which returned -48% over the past year.
Return vs Market: CTE exceeded the Australian Market which returned 3.5% over the past year.
Price Volatility
| CTE volatility | |
|---|---|
| CTE Average Weekly Movement | 8.0% |
| Life Sciences Industry Average Movement | 9.1% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in AU Market | 15.7% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: CTE is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: CTE's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 22 | John Hogg | https://www.cryosite.com |
Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns management, comparator sourcing, import, export, validated transport, and biological storage solutions to the clinical trials, and research and pharmaceutical industry.
Cryosite Limited Fundamentals Summary
| CTE fundamental statistics | |
|---|---|
| Market Cap | AU$35.39m |
| Earnings (TTM) | AU$1.36m |
| Revenue (TTM) | AU$11.76m |
25.9x
P/E Ratio3.0x
P/S RatioIs CTE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CTE income statement (TTM) | |
|---|---|
| Revenue | AU$11.76m |
| Cost of Revenue | AU$4.92m |
| Gross Profit | AU$6.84m |
| Other Expenses | AU$5.47m |
| Earnings | AU$1.36m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.028 |
| Gross Margin | 58.16% |
| Net Profit Margin | 11.60% |
| Debt/Equity Ratio | 0% |
How did CTE perform over the long term?
See historical performance and comparison